Harness the potential of ketamine.

Ketamine is a revolutionary treatment for the mind. It can quickly—sometimes within an hour or two—alleviate the effects of anxiety, depression, and related conditions.

A reliable and commonly-prescribed treatment

Ketamine received FDA approval in 1970 as an anesthetic and pain reliever, and has appeared on the World Health Organization’s Essential Medicines List since 1985.
Ketamine is likewise prescribed off-label to address a broad spectrum of mental health conditions.

An encouraging therapy for mental wellness

Recognized for its anesthetic properties and healing potential, ketamine is progressively being utilized as a therapy for anxiety and depression.
In smaller doses, ketamine can interrupt harmful emotions and fixations and support the brain in forming new, healthier pathways.

How does it function?

Ketamine works within the brain to deliver relief from anxiety and depression.

Boost neural growth

When individuals experience long-term anxiety and depression, their neurons become weakened with reduced connections.
Ketamine aids in repairing this harm by promoting neuroplasticity and nourishing the brain, rebuilding and reinforcing fresh connections among neurons.

Lessen harmful thoughts

Ketamine may also provide relief from harmful thoughts by balancing activity in a brain region called the default mode network.
Through shifting connectivity in this brain region, ketamine can assist individuals in escaping old thought patterns that fuel anxiety and depression while enhancing mood.

Sense of relief

By briefly quieting harmful thoughts, ketamine therapy can provide much needed comfort and recovery.

“Ketamine quieted the endless thoughts that have been tormenting me for the majority of my life.”

Jeff, IT Business Owner

“Since using Ketcare, I’ve found relief from my depression and anxiety.”

Amanda, Administrative Assistant

“My journey concluded with the realization that everything will turn out okay.”

Calm experience

Gentle experience

Although each person’s journey is unique, many clients describe their Ketcare sessions as calm.

“The most unexpected aspect of my Ketcare experience was how calm and secure it felt.”

Brenna, Writer

“I anticipated a blow to the face, yet it felt more like a light tickle on the arm.”

Brittni, Project Manager

“I value the comfort and security of my own living room.”

Noah, Land Use Consultant

Fresh perspective

Ketamine therapy enables fresh perspectives that can assist us in processing and moving beyond pain.

“Ketcare gave me a clearer perspective on anxiety, depression, and life itself.”

Deborah, Student

“I’ve transformed my harmful thoughts into positive ones.”

Sarah

“Ketcare helped establish a foundation I needed to prevent me from spiraling and feeling lost.”

Andrew, Financial Advisor

Important Safety Information

Ketcare connects individuals with licensed clinicians trained to diagnose and treat mental health conditions such as anxiety, depression, and other disorders. If a clinician determines, based on their professional judgment and a clinical evaluation, that ketamine is a suitable treatment for a patient, they may prescribe compounded ketamine tablets. These tablets are prepared by pharmacies under Section 503A of the federal Food, Drug, and Cosmetic Act (FDCA). Compounded drugs under Section 503A are not subject to FDA approval, meaning the FDA has not evaluated the safety or efficacy of compounded ketamine for treating anxiety, depression, or other mental health conditions. However, a body of scientific research supports the use of ketamine for these conditions.
Ketamine is classified as a Schedule III controlled substance. Other ketamine-containing medications, which are subject to FDA approval (unlike compounded drugs), are approved as intravenous or intramuscular injections for general anesthesia induction and maintenance. These medications are not FDA-approved for mental health conditions like anxiety or depression, nor are they approved in tablet form.
Potential Risks of Ketamine
Ketamine may cause serious side effects, including but not limited to:
Sedation
Dissociation
Worsening of psychiatric conditions, including issues in individuals with schizophrenia, severe personality disorders, or other serious mental health conditions
Dependence, abuse, or misuse
Anxiety
Increased blood pressure or heart rate
Respiratory depression (slow, shallow breathing that impairs gas exchange)
Lower urinary tract or bladder issues, such as frequent urination, incontinence, painful urination, blood in the urine, or reduced bladder size
The FDA has noted that at-home use of compounded ketamine may carry additional risks due to the absence of an on-site healthcare provider to monitor for adverse effects, such as sedation or dissociation.
Ketcare’s protocols are carefully designed to reduce the likelihood of side effects or adverse events and must be strictly followed. Ketamine should only be used as prescribed by the treating clinician.
Who Should Avoid Ketamine Treatment

Do not proceed with ketamine treatment if any of the following apply:

Ketamine may lead to moderate psychological dependency in some users. In rare cases, frequent and heavy use has been associated with urinary issues, including increased urination frequency, incontinence, painful urination, blood in the urine, or reduced bladder size. Ketamine may exacerbate symptoms in individuals with schizophrenia, severe personality disorders, or other serious mental conditions. Those with a personal or family history of psychosis should consult their clinician about potential risks before starting treatment, as ketamine’s dissociative effects may increase vulnerability or the risk of accidents.

Ketamine Treatment Guidelines

To ensure safety and optimize outcomes, adhere to these guidelines:

Clinical Evidence

A peer-reviewed study on Ketcare’s client outcomes, published in the Journal of Affective Disorders in 2022, titled At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial, demonstrated positive results. The FDA has not conducted head-to-head trials comparing ketamine’s safety to other FDA-approved treatments for depression, anxiety, or other psychiatric disorders. While some clients report better outcomes with ketamine than with FDA-approved therapies, these results may not be typical. For more details on the informed consent process, visit [Ketcare’s informed consent page](insert link).

Why Choose Ketcare?

Convenient, Affordable At-Home Care: Experience premium treatment from the comfort of your home.
Comprehensive Support System: Beyond medication, Ketcare offers robust clinical and community support.
Neuroplasticity-Based Treatment: Ketamine promotes brain rewiring to foster healing and growth.
Trusted by Clinicians, Backed by Science: Ketcare is a leading provider supported by clinical research.
Transformative Mental Health Care: Ketamine helps rewire neural pathways, offering a new approach to mental wellness.